Undark
On Dec. 30, I received the email nearly everybody on Earth is praying for. The subject line wasn’t exactly scintillating - “Order available for scheduling, it read. But it could only mean one thing: I, along with other students at my medical school, was getting the Covid-19 vaccine.
Please share this article - Go to very top of page, right hand side, for social media buttons.
As I blanked on my password for the scheduling portal, however, hesitation crept in. Although I’ll return to clinical duties in the coming months, I haven’t served on the front lines during the pandemic. I’m currently on leave, working toward another degree and reporting for a project memorializing health care workers who have died from Covid-19. And when I haven’t been speaking to families who’ve lost loved ones, I’ve been checking in with friends from medical school who are now resident physicians across the country. Or I’ve been video chatting with my 91-year-old grandmother, my
Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
New York City Health Commissioner Dr. Dave Chokshi announced on Wednesday, Feb. 3, that he has tested positive for the Wuhan coronavirus (COVID-19). Chokshi, 39, said that he was experiencing [.]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Neovasc Comments on Journal of the American Heart Association Publication
Neovasc, Inc.February 5, 2021 GMT
VANCOUVER and MINNEAPOLIS, Feb. 05, 2021 (GLOBE NEWSWIRE) via NewMediaWire Neovasc, Inc. (“Neovasc” or the “Company”) ( NASDAQ, TSX: NVCN) today announced that the Journal of the American Heart Association has published an article entitled, “Angina Severity, Mortality, and Healthcare Utilization Among Veterans with Stable Angina”. The prestigious journal is the official publication of the American Heart Association, and the article offers important insights into the burden of angina on both patients and healthcare systems.
Global consulting giant McKinsey & Company agrees to pay $573million settlement for role in opioid crisis after advising drug companies on how to supercharge sales
McKinsey & Co. agreed to $573million settlement with 47 states, DC, and 5 US territories over its role in advising OxyContin maker Purdue Pharma
Criticism of McKinsey escalated since New York Times report from November claimed the firm advised Purdue Pharma on ways to supercharge drug sales
In December, McKinsey apologized for its work with Purdue Pharma and vowed to probe claims two senior partners discussed deleting records linked to firm
McKinsey reportedly proposed that Purdue Pharma pay distributors rebates for overdoses linked to the pills sold by the company